ROIV
Roivant Sciences Ltd
35.70$
+0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -16.1% | +334.6% | +163.4% | -48.9% | +80.8% | +74.0% | -62.1% | -53.2% | +190.2% | +36.1% | +60.5% | -21.0% | -83.1% | +326.6% | +85.9% | -84.5% | +0.0% | +101.5% | -16.1% | -71.3% | -27.6% | +27.2% | +26.1% | -42.8% | – | |
| – | – | +297.2% | -4.3% | -30.1% | +55.2% | +760.0% | -78.3% | -66.8% | +276.0% | +111.0% | +128.6% | +12.8% | -55.1% | -94.7% | -11.7% | +2,139.6% | -94.7% | +0.0% | +10.7% | -20.8% | -24.9% | -27.9% | +530.6% | -54.3% | -11.3% | – | |
| – | – | -56.4% | +733.2% | +189.5% | -52.3% | +8.8% | +201.8% | -61.8% | -70.4% | +242.9% | -1.8% | +106.1% | -3.2% | -80.3% | +348.6% | +59.6% | -82.7% | +0.0% | +106.5% | -15.9% | -72.6% | -27.6% | -11.0% | +69.4% | -47.4% | – | |
| – | – | +65.8% | +107.6% | -39.8% | -35.4% | +223.4% | -39.6% | -12.0% | +0.6% | -2.8% | -4.9% | +5.0% | -5.1% | -8.3% | -5.8% | +11.8% | +18.3% | -0.5% | -0.5% | +2.6% | +5.3% | +7.6% | +0.5% | +20.3% | +1.5% | – | |
| – | – | +4.6% | +3.6% | +31.1% | +2.0% | +429.0% | -73.6% | +20.3% | +7.3% | +5.8% | +6.7% | -25.4% | +24.4% | -43.3% | +44.7% | +53.9% | +2.8% | +0.0% | -30.2% | +3.9% | -8.9% | +6.8% | +22.3% | -9.6% | +4.6% | – | |
| – | – | +35.6% | +68.1% | -115.4% | – | +328.8% | -61.1% | +1.9% | +4.0% | +1.7% | -0.2% | -12.8% | +16.5% | -26.0% | -2,452.4% | – | +19.1% | +0.0% | -18.2% | +3.2% | -1.8% | +7.2% | +10.6% | +4.9% | +2.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -105.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | +8.4% | -98.2% | +1,331.4% | +131.4% | +558.9% | -91.9% | -91.1% | -23.7% | +219.1% | +1.3% | +1.5% | +3.9% | +3.8% | +2.1% | -24.0% | +86.7% | +0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -103.7% | – | – | – | – | – | – | – | – | -164.9% | – | |
| – | -57.0% | -41.8% | -131.5% | – | – | +331.2% | -90.5% | -528.9% | – | -45.9% | +30.2% | -234.6% | – | +84.7% | +591.1% | -140.0% | – | +0.0% | -305.2% | – | -90.6% | +50.5% | +233.6% | +321.5% | -104.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -103.0% | – | – | – | -221.9% | – | – | – | – | -162.7% | – | |
| – | – | – | – | – | -187.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -163.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.